Patient Perceptions of Three Substance Use Screening Tools for Use During Pregnancy.

Patient Perceptions of Three Substance Use Screening Tools for Use During Pregnancy.
复制标题

患者对怀孕期间使用的三种药物使用筛查工具的看法。

DOI:
10.1007/s10995-022-03442-1
复制
发表时间:
2022
影响因子:
2.3
通讯作者:
Coleman-Cowger,VictoriaH
Coleman-Cowger,VictoriaH
中科院分区:
医学4区
文献类型:
--
作者:
Trocin,KathleenE;Oga,EmmanuelA;Mulatya,Caroline;Mark,KatrinaS;Coleman-Cowger,VictoriaH

文献摘要

相似文献

本研究的目的是了解孕妇对三种有效的物质使用筛查工具的看法,并确定在怀孕期间使用的首选工具。研究的三种筛查工具包括4P‘s Plus,NIDA快速筛查/NIDA修改的酒精,吸烟和物质参与筛查测试,以及物质使用风险概况-妊娠量表。方法从2017年1月到2018年1月,在马里兰州巴尔的摩,对参加两次产科实践的不同样本的孕妇进行了493次认知访谈。这项研究作为一个更大的研究的定性伙伴,比较了产前护理中物质使用筛查工具的准确性和可接受性。在完成每个筛选工具后,参与者被问及他们对该工具的看法,并选择他们喜欢的工具。访谈被记录下来,逐字转录,编码,并使用NVivo软件进行分析。结果大多数参与者(43.4%)表示他们更喜欢4P‘s Plus。喜欢NIDA Quick Screen(32.5%)和Surp-P(24.1%)的参与者较少。与会者认为,4P的Plus既全面又简洁。虽然许多参与者认为药物使用情况的披露会因个人而异,但参与者也建议,如果筛查是保密的,包括关于患者背景的问题,并由非评判的提供者进行管理,孕妇可能更有可能诚实回答。结论实用4P‘s Plus是一种有前途的、可接受的产前护理药物使用筛查工具。临床医生可以使用几种方法来提高物质使用筛查的可接受性,并鼓励披露产前物质使用情况。
ObjectivesThe purpose of this study was to understand pregnant women’s perceptions of three validated substance use screening tools and identify a preferred tool for use during pregnancy. The three screening tools studied included the 4P’s Plus, the NIDA Quick Screen/ NIDA-Modified Alcohol, Smoking and Substance Involvement Screening Test, and the Substance Use Risk Profile-Pregnancy Scale.MethodsA total of 493 cognitive interviews were completed with a diverse sample of pregnant women presenting to two obstetrics practices in Baltimore, MD from January 2017 to January 2018. This study served as a qualitative companion to a larger study comparing the accuracy and acceptability of substance use screening tools in prenatal care. After completing each screening tool, participants were asked their perceptions of the tool and to choose their preferred tool. Interviews were recorded, transcribed verbatim, coded, and analyzed using NVivo software.ResultsThe plurality of participants (43.4%) reported they preferred the 4P’s Plus. Fewer participants preferred the NIDA Quick Screen (32.5%) and the SURP-P (24.1%). Participants felt that the 4P’s Plus was both comprehensive and concise. While many participants felt that disclosure of substance use would vary by individual, participants also suggested that when screening is confidential, includes questions about a patient’s background, and administered by a non-judgmental provider, pregnant people may be more likely to answer honestly.Conclusions for PracticeThe 4P’s Plus is a promising and acceptable substance use screening tool for use in prenatal care. Clinicians can use several methods to increase acceptability of substance use screening and encourage disclosure of prenatal substance use.